The Neutrogena Rapid Clear Stubborn Acne Facial Cleanser is a benzoyl peroxide treatment in a gentle cleanser designed for daily use on the face. This 125 ML bottle helps address stubborn acne with a clear, practical routine suitable for those dealing with persistent breakouts.
Key benefits
- Uses benzoyl peroxide to help clear acne-prone skin when used as directed.
- Gently cleanses while delivering an acne-focused treatment to the skin surface.
- Parfum-free or low-fragrance formulation aids common-sense skin care routines.
- Part of a twice-daily usage plan, adjustable based on skin tolerance and progress.
- New Users guidance minimizes initial irritation by testing a small area first.
Ingredients and key components
- Benzoyl Peroxide (3.5%) — a medicinal ingredient that helps reduce acne-causing bacteria on the skin surface when used as directed.
- Non-medicinal ingredients include Bentonite, Benzyl Alcohol, Citric Acid, Disodium EDTA, Glycerin, Kaolin, Menthol, Parfum, Sodium Citrate, Sodium Hydroxide, Sodium Methyl Cocoyl Taurate, Titanium Dioxide, Water, Xanthan Gum.
Usage guidance and suitability
- Wet face and gently massage the cleanser over the face, avoiding the eye area.
- Rinse thoroughly with water and pat dry.
- Apply twice daily or as directed by a doctor.
- New Users: Apply to a small area once daily for 3 days to test for sensitivity; if no discomfort occurs, apply to entire affected area and rinse off.
- Start with 1 application, gradually increasing to 2-3 times daily if needed; if dryness or peeling occurs, reduce to once a day or every other day.
Storage: keep out of reach of children. Follow the included product instructions for dosage and usage times. This description mirrors the product’s official directions and ingredients to help you make an informed choice.
Disclaimer: This product is not intended to diagnose, treat, cure, or prevent any disease. Always read and follow the product label. Consult a healthcare professional if you have any health concerns.









Reviews
There are no reviews yet.